利用单锅氨基化-环化级联反应合成 3,4,5-三羟基哌啶并抑制糖苷酶。

IF 2.4 3区 化学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY
Emma M. Dangerfield , Michael A. Meijlink , Alex A. Hunt-Painter , Seyed A. Nasseri , Stephen G. Withers , Bridget L. Stocker , Mattie S.M. Timmer
{"title":"利用单锅氨基化-环化级联反应合成 3,4,5-三羟基哌啶并抑制糖苷酶。","authors":"Emma M. Dangerfield ,&nbsp;Michael A. Meijlink ,&nbsp;Alex A. Hunt-Painter ,&nbsp;Seyed A. Nasseri ,&nbsp;Stephen G. Withers ,&nbsp;Bridget L. Stocker ,&nbsp;Mattie S.M. Timmer","doi":"10.1016/j.carres.2024.109198","DOIUrl":null,"url":null,"abstract":"<div><p>Trihydroxypiperidines are a therapeutically valuable class of iminosugar. We applied a one-pot amination-cyclisation cascade reaction to synthesise 3,4,5-trihydroxypiperidine stereoisomers in three steps from commercially available pentoses and in excellent overall yields. Using our methodology, the yields of the syntheses of <strong><em>meso</em>-1</strong>, <strong><em>meso</em>-2</strong> and <strong>3L</strong> are the highest reported to date. The synthetic methodology was readily extended to the three-step synthesis of <em>N</em>-alkyl derivatives by replacing the ammonia nitrogen source with a primary amine. The trihydroxypiperidines and <em>N</em>-alkyl analogues were screened for enzyme inhibitory activity using Fabrazyme (Fabry disease), GCase (Gaucher's disease), <em>Agrobacterium</em> sp. β-glucosidase, and <em>Escherichia coli</em> β-galactosidase. <em>N</em>-Phenylethyl 3,4,5-trihydroxypiperidine (<em>N</em>-phenylethyl-1-(3<em>R</em>,4<em>R</em>,5<em>S</em>)-piperidine-3,4,5-triol) showed good inhibitory activity of Fabrazyme (<em>K</em><sub>i</sub> = 46 μM). This activity was abolished when the <em>N</em>-phenylethyl group was removed or replaced with a non-aromatic alkyl chain.</p></div>","PeriodicalId":9415,"journal":{"name":"Carbohydrate Research","volume":null,"pages":null},"PeriodicalIF":2.4000,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S0008621524001770/pdfft?md5=d0a10f2048fed1a52bbd104f83b6ed34&pid=1-s2.0-S0008621524001770-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Synthesis and glycosidase inhibition of 3,4,5-trihydroxypiperidines using a one-pot amination-cyclisation cascade reaction\",\"authors\":\"Emma M. Dangerfield ,&nbsp;Michael A. Meijlink ,&nbsp;Alex A. Hunt-Painter ,&nbsp;Seyed A. Nasseri ,&nbsp;Stephen G. Withers ,&nbsp;Bridget L. Stocker ,&nbsp;Mattie S.M. Timmer\",\"doi\":\"10.1016/j.carres.2024.109198\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Trihydroxypiperidines are a therapeutically valuable class of iminosugar. We applied a one-pot amination-cyclisation cascade reaction to synthesise 3,4,5-trihydroxypiperidine stereoisomers in three steps from commercially available pentoses and in excellent overall yields. Using our methodology, the yields of the syntheses of <strong><em>meso</em>-1</strong>, <strong><em>meso</em>-2</strong> and <strong>3L</strong> are the highest reported to date. The synthetic methodology was readily extended to the three-step synthesis of <em>N</em>-alkyl derivatives by replacing the ammonia nitrogen source with a primary amine. The trihydroxypiperidines and <em>N</em>-alkyl analogues were screened for enzyme inhibitory activity using Fabrazyme (Fabry disease), GCase (Gaucher's disease), <em>Agrobacterium</em> sp. β-glucosidase, and <em>Escherichia coli</em> β-galactosidase. <em>N</em>-Phenylethyl 3,4,5-trihydroxypiperidine (<em>N</em>-phenylethyl-1-(3<em>R</em>,4<em>R</em>,5<em>S</em>)-piperidine-3,4,5-triol) showed good inhibitory activity of Fabrazyme (<em>K</em><sub>i</sub> = 46 μM). This activity was abolished when the <em>N</em>-phenylethyl group was removed or replaced with a non-aromatic alkyl chain.</p></div>\",\"PeriodicalId\":9415,\"journal\":{\"name\":\"Carbohydrate Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2024-06-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S0008621524001770/pdfft?md5=d0a10f2048fed1a52bbd104f83b6ed34&pid=1-s2.0-S0008621524001770-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Carbohydrate Research\",\"FirstCategoryId\":\"92\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0008621524001770\",\"RegionNum\":3,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Carbohydrate Research","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0008621524001770","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

三羟基哌啶是一类具有治疗价值的亚氨基糖。我们采用一锅胺化-环化级联反应,从市售的戊糖出发,分三步合成了 3,4,5-三羟基哌啶立体异构体,而且总收率极高。使用我们的方法合成介-1、介-2 和 3L 的收率是迄今为止所报道的最高的。通过用伯胺代替氨氮源,合成方法很容易扩展到三步合成 N-烷基衍生物。利用法布雷酶(法布雷病)、GCase(戈谢病)、农杆菌β-葡萄糖苷酶和大肠杆菌β-半乳糖苷酶对三羟基哌啶和 N-烷基类似物的酶抑制活性进行了筛选。N- 苯乙基 3,4,5-三羟基哌啶(N-苯乙基-1-(3R,4R,5S)-哌啶-3,4,5-三醇)对法布拉酶具有良好的抑制活性(Ki = 46 μM)。当 N-苯基乙基被移除或被非芳香族烷基链取代时,这种活性就会消失。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Synthesis and glycosidase inhibition of 3,4,5-trihydroxypiperidines using a one-pot amination-cyclisation cascade reaction

Synthesis and glycosidase inhibition of 3,4,5-trihydroxypiperidines using a one-pot amination-cyclisation cascade reaction

Trihydroxypiperidines are a therapeutically valuable class of iminosugar. We applied a one-pot amination-cyclisation cascade reaction to synthesise 3,4,5-trihydroxypiperidine stereoisomers in three steps from commercially available pentoses and in excellent overall yields. Using our methodology, the yields of the syntheses of meso-1, meso-2 and 3L are the highest reported to date. The synthetic methodology was readily extended to the three-step synthesis of N-alkyl derivatives by replacing the ammonia nitrogen source with a primary amine. The trihydroxypiperidines and N-alkyl analogues were screened for enzyme inhibitory activity using Fabrazyme (Fabry disease), GCase (Gaucher's disease), Agrobacterium sp. β-glucosidase, and Escherichia coli β-galactosidase. N-Phenylethyl 3,4,5-trihydroxypiperidine (N-phenylethyl-1-(3R,4R,5S)-piperidine-3,4,5-triol) showed good inhibitory activity of Fabrazyme (Ki = 46 μM). This activity was abolished when the N-phenylethyl group was removed or replaced with a non-aromatic alkyl chain.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Carbohydrate Research
Carbohydrate Research 化学-生化与分子生物学
CiteScore
5.00
自引率
3.20%
发文量
183
审稿时长
3.6 weeks
期刊介绍: Carbohydrate Research publishes reports of original research in the following areas of carbohydrate science: action of enzymes, analytical chemistry, biochemistry (biosynthesis, degradation, structural and functional biochemistry, conformation, molecular recognition, enzyme mechanisms, carbohydrate-processing enzymes, including glycosidases and glycosyltransferases), chemical synthesis, isolation of natural products, physicochemical studies, reactions and their mechanisms, the study of structures and stereochemistry, and technological aspects. Papers on polysaccharides should have a "molecular" component; that is a paper on new or modified polysaccharides should include structural information and characterization in addition to the usual studies of rheological properties and the like. A paper on a new, naturally occurring polysaccharide should include structural information, defining monosaccharide components and linkage sequence. Papers devoted wholly or partly to X-ray crystallographic studies, or to computational aspects (molecular mechanics or molecular orbital calculations, simulations via molecular dynamics), will be considered if they meet certain criteria. For computational papers the requirements are that the methods used be specified in sufficient detail to permit replication of the results, and that the conclusions be shown to have relevance to experimental observations - the authors'' own data or data from the literature. Specific directions for the presentation of X-ray data are given below under Results and "discussion".
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信